Notably, G2 and S-Phase Expressed 1 (GTSE1) gene, a p53 activity repressor, was found to be dose-dependently induced by CDDP treatment in GC cells and its knock-down enhanced p53-mediated apoptosis in response to CDDP [151]. The gene discussed is TP53; the disease is gastric cancer.